Your session is about to expire
← Back to Search
Epclusa for Chronic Hepatitis C
Study Summary
This trial will study why some people still have liver complications after being cured of hepatitis C. Eligible participants will have different tests and some will take medication for 12 weeks. Then they will have follow-up visits for up to 10 years.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 & 3 trial • 10 Patients • NCT02825212Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had successful hepatitis treatment with medication and a liver biopsy before treatment.I have previously been treated with an NS5a agent.I do not have major health issues that could affect my participation in the study.I am not pregnant or breastfeeding.I do not have major health issues that could affect my participation in the study.I have either never been treated or have not responded to previous hepatitis treatments.I have had chronic hepatitis C confirmed by a test more than 6 months ago.I am 18 years old or older.I have chronic hepatitis C confirmed by a liver biopsy.I am 18 years old or older.My overall health is good, as confirmed by my doctor.
- Group 1: Phase II after Phase I
- Group 2: Phase I
- Group 3: Phase II without Phase I
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA granted approval of Epclusa?
"The safety of Epclusa has been confirmed by multiple clinical trials, earning it a score of 3. This is noteworthy as this drug is already approved and currently available to patients."
Are there any available slots in this clinical trial for prospective participants?
"Clinicaltrials.gov currently lists this trial as actively recruiting participants, with the initial posting occurring on October 19th 2018 and a recent update on October 22nd 2022."
Could you provide an estimate of the number of individuals currently enrolled in this clinical exploration?
"Affirmative. Per the data hosted on clinicaltrials.gov, this research is still accepting patients as of October 22nd 2022, having originally been posted four years earlier on October 19th 2018. 450 participants are being sought out from a single medical centre."
Share this study with friends
Copy Link
Messenger